SynthesisDiabetologia2024

Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.

Sarah Meulebrouck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.